Review compares approaches to preventing cardiovascular disease
A review of randomized trials favored several prevention approaches, but its abstract leaves the outcome grouping unclear and offers limited evidence for choosing between specific options.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review reported favorable results for blood pressure medicines, tighter blood pressure control, statins and programs combining lifestyle changes. However, the abstract groups these results under “composite cardiovascular events and mortality” without clearly separating the outcomes. This summary therefore cannot establish which approaches reduced cardiovascular events, deaths, or both as separate outcomes.
This abstract-based explanation cannot resolve how the reported risk ratios map to individual outcomes or reference groups. The authors also note possible residual confounding and limited direct comparisons.
What the review examined
The researchers brought together trials of medicines, nutritional supplements, lifestyle changes, behavioral approaches and health policies. They assessed deaths from any cause, cardiovascular events, coronary heart disease and cardiovascular deaths to compare approaches to primary prevention.
What remains uncertain
Few trials directly compared specific approaches, limiting the distinctions the review could make between them. The authors described other interventions’ effects as unclear; that uncertainty should not be read as evidence that those interventions have no effect.
The original publication
Identifying optimal primary prevention interventions for major cardiovascular disease events and all-cause mortality: a systematic review and hierarchical network meta-analysis of RCTs.
Uthman OA, Court R, Enderby J et al.
Health Technol Assess · 2025
- PubMed ID
- 40611785
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.